Navigation Links
World Financial Crisis and AIDS Backlash Threaten Lives
Date:7/7/2009

KAMPALA, Uganda and NAIROBI, Kenya and DELHI, India, July 7 /PRNewswire-USNewswire/ -- On the eve of the G8 Summit in Italy, the International Treatment Preparedness Coalition (ITPC) calls on leaders of the world's richest countries to announce significant additional funds to ensure that AIDS treatment and prevention programs for millions of men, women and children do not become a casualty of the economic down-turn.

"Cutting funds for HIV programs would be a clear disaster for the four million people already on treatment, the seven million people who need treatment and millions more who need effective HIV prevention programmes," said Aditi Sharma, coordinator of the Treatment Monitoring and Advocacy Project of ITPC. "We call on the G8 to commit their fair share towards meeting the Universal Access target -- a first step would be to plug the $5 billion funding gap for the Global Fund to Fight AIDS, TB and Malaria."

Reacting to a new report from UNAIDS and the World Bank(1), which found that the global economic crisis has already disrupted AIDS treatment programmes in eight countries and is expected to impact programs in an additional 21 countries by the end of this year, activists from around the world called on all governments to ensure sustained funding for HIV programmes and put in place early warning systems that alert them to impending drug stock-outs and treatment interruptions.

"Let us be completely clear about what this report is saying," said Gregg Gonsalves, co-founder of ITPC. "People living with HIV/AIDS, who are now receiving treatment, are in danger of losing their drugs because of cutbacks and funding reallocations. Many of those people will die. We cannot allow AIDS backlash or the current economic situation to be used as excuses for failing to meet commitments."

"We must continue to scale up and sustain AIDS treatment and prevention programmes in Eastern African countries,
'/>"/>

SOURCE International Treatment Preparedness Coalition
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. IBM Award for Innovative Solution to Tackling Worlds Most Critical Social and Environmental Problems
2. New Report Just Published: World Telemedicine Market Report
3. New Report Just Published: World Multiple Myeloma Therapeutics Market Report
4. New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
5. Rare sheep could be key to better diagnostic tests in developing world, says Stanford study
6. Scienceroll.com on the Medical Implications of Virtual Worlds
7. CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications
8. News media registration open for 20th World Diabetes Congress
9. New York Citys World Product Centre Announces Initial Charter Partners
10. Canadian Bio Med Attacks Worlds Leading Cause of Blindness
11. Renowned Medical Tourism Industry Expert and Author Josef D. Woodman Joins Satori World Medical's Strategic Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Orexigen 28R 29 Therapeutics to Speak at Canaccord Adams Global Growth Conference 13397 1Pharmasset to Present at Canaccord Adams Conference 13394 1Pharmasset to Present at Canaccord Adams Conference 13394 2Pharmasset to Present at Canaccord Adams Conference 13394 3Autism May Hinder Ability to Read Body Language 53773 1Autism May Hinder Ability to Read Body Language 53773 2